Citi raises Krystal Biotech price target to $386

August 3, 2026 2:59 PM

Citi analyst Yigal Nochomovitz raised the price target on Krystal Biotech (NASDAQ: KRYS) to $386 from $378, while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found